SU-1644

N/A

Report date: 2025/06/11 10:43:29
NME

Base Information

Drug NameSU-1644
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit alpha inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit alpha
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Strathclyde
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of StrathclydeUniversity Of Glasgow
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A